{
  "id": "2247620089_3",
  "title": "复星医药与梯瓦达成战略合作，共同开发抗 PD1-IL2 疗法",
  "content": "<div class=\"rich_media_content js_underline_content autoTypeSetting24psection\" id=\"js_content\">\n <section data-mpa-action-id=\"mbyjgkeu1wcz\" nodeleaf=\"\" style='color: rgba(0, 0, 0, 0.9);font-size: 17px;font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;line-height: 1.75em;letter-spacing: 0.034em;font-style: normal;font-weight: normal;margin-left: 8px;margin-right: 8px;margin-bottom: 24px;'>\n  <img class=\"rich_pages wxw-img\" data-backh=\"238\" data-backw=\"562\" data-imgfileid=\"100134991\" data-ratio=\"0.42340425531914894\" data-s=\"300,640\" data-type=\"png\" data-w=\"940\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8sEopW5Xekud7JicHnPibBhUqrlCrCB2npo4f3AJxr0bcbc9URAQ6yZIsCicGUFjgx2y0wPet197e9kw/640?wx_fmt=png&amp;from=appmsg\" style=\"width:100%;\" type=\"block\"/>\n </section>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\">\n  <span data-mpa-action-id=\"mbzxc12z1iwe\" leaf=\"\" style=\"font-size: 15px;\">\n   6 月 16 日，复星医药与 Teva Pharmaceutical Industries（梯瓦）共同宣布，双方通过各自的子公司，就\n  </span>\n  <span data-mpa-action-id=\"mbzxc12z1iwe\" data-pm-slice='1 1 [\"para\",{\"tagName\":\"p\",\"attributes\":{\"style\":\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\" style=\"font-size: 15px;\">\n   梯瓦的\n  </span>\n  <span data-mpa-action-id=\"mbzxc12z1iwe\" leaf=\"\" style=\"font-size: 15px;\">\n   在研药物\n   <span style=\"font-weight: bold;\" textstyle=\"\">\n    抗 PD1-IL2 ATTENUKINE™疗法 TEV-56278\n   </span>\n   的开发达成战略合作。\n  </span>\n </p>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 8px;\">\n  <img class=\"rich_pages wxw-img\" data-backh=\"224\" data-backw=\"578\" data-imgfileid=\"100136440\" data-ratio=\"0.38809831824062097\" data-s=\"300,640\" data-type=\"png\" data-w=\"773\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8u9QmZtgeEsojnsIfYq2PovxJ0MqZibq1RY3nLiaibgHSAaxoDMZA1e9TA1BpVNhxxZBQuSjVdtakHNA/640?wx_fmt=png&amp;from=appmsg\" style=\"width: 100%;\" type=\"block\"/>\n </section>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;text-align: center;\">\n  <span data-pm-slice=\"0 0 []\" style='color: rgb(178, 178, 178);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 12px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.408px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;'>\n   <span leaf=\"\">\n    来源：企业官微\n   </span>\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\">\n  <span leaf=\"\" style=\"font-size: 15px;\">\n   TEV-56278 是一种抗 PD-1 抗体-细胞因子融合蛋白，旨在选择性地将减毒的白细胞介素-2（IL-2），即 ATTENUKINE™，递送至肿瘤微环境内表达 PD-1 的 T 细胞。\n   <span style=\"font-weight: bold;\" textstyle=\"\">\n    这种靶向疗法旨在增强 T 细胞抗肿瘤活性，同时最大限度地降低毒性\n   </span>\n   。\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\">\n  <span leaf=\"\" style=\"font-size: 15px;\">\n   目前，TEV-56278 正在进行单药治疗以及与帕博利珠单抗联合治疗的探索。临床前数据已证明其可促使肿瘤消退、增强 T 细胞浸润并建立持久的免疫记忆。\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\">\n  <span data-mpa-action-id=\"mbzxc12zdz5\" leaf=\"\" style=\"font-size: 15px;\">\n   根据协议，为加速临床数据开发，\n   <span style=\"font-weight: bold;\" textstyle=\"\">\n    复星医药将获得 TEV-56278 在中国\n   </span>\n   <span style=\"color: rgb(136, 136, 136);font-weight: bold;\" textstyle=\"\">\n    （包括港澳台地区）\n   </span>\n   <span style=\"font-weight: bold;\" textstyle=\"\">\n    以及特定东南亚国家的独家开发、生产和商业化许可\n   </span>\n   。梯瓦则保留 TEV-56278 在全球其他地区的开发、生产与商业化权利。\n  </span>\n </p>\n <p style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;\">\n  <span data-mpa-action-id=\"mbzxc12zdz5\" leaf=\"\" style=\"font-size: 15px;\">\n   此次战略合作将为 TEV-56278 全球化开发注入强大动力，双方将共享临床开发数据，加速这一创新疗法的研发进展。\n  </span>\n </p>\n <p style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;text-align: left;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;visibility: visible;\">\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;color: rgb(163, 163, 163);\">\n     <span leaf=\"\">\n      封面来源：\n     </span>\n    </span>\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;\">\n     <span style=\"color:#b2b2b2;\">\n     </span>\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;\">\n    <span style=\"color:#b2b2b2;\">\n     <span leaf=\"\">\n      企业logo\n     </span>\n    </span>\n   </span>\n  </span>\n </p>\n <p style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 15px;visibility: visible;color: rgb(178, 178, 178);\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     免责声明：\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;letter-spacing: 0.544px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     本文仅作信息分享，不代表 Insight 立场和观点，也不作治疗方案推荐和介绍。如有需求，请咨询和联系正规医疗机构。\n    </span>\n   </span>\n  </span>\n </p>\n <p style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: system-ui, -apple-system, system-ui, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: left;visibility: visible;line-height: 1.75em;'>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </p>\n <p style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;color: rgb(178, 178, 178);\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;\">\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      编辑：馨药\n     </span>\n     <span leaf=\"\">\n      <br/>\n     </span>\n    </span>\n   </strong>\n  </span>\n </p>\n <p style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;color: rgb(178, 178, 178);\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;\">\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      PR 稿对接\n     </span>\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     ：微信 insightxb\n    </span>\n   </span>\n  </span>\n </p>\n <section style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;text-align: left;line-height: 1.75em;margin-bottom: 24px;'>\n  <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;color: rgb(178, 178, 178);\">\n   <strong style=\"-webkit-tap-highlight-color: transparent;outline: 0px;visibility: visible;\">\n    <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      投稿\n     </span>\n    </span>\n   </strong>\n   <span style=\"-webkit-tap-highlight-color: transparent;outline: 0px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     ：微信 insightxb；邮箱 insight@dxy.cn\n    </span>\n   </span>\n  </span>\n </section>\n <section style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <span leaf=\"\">\n   <img class=\"rich_pages wxw-img\" data-imgfileid=\"100133276\" data-ratio=\"0.6319148936170212\" data-s=\"300,640\" data-type=\"png\" data-w=\"940\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vJ9AD3IliaMYHfGS36BCmzgFCmSaH97qfZGwxsicbb6ibA9sP4ZA3JVDDCSaEhHfHBD0nh8TMftib9UQ/640?wx_fmt=png&amp;from=appmsg\"/>\n   <img class=\"rich_pages wxw-img\" src=\"/static/res/logo/\"/>\n   <img class=\"rich_pages wxw-img\" src=\"/static/res/logo/\"/>\n   <img class=\"rich_pages wxw-img\" src=\"/static/res/logo/\"/>\n   <img class=\"rich_pages wxw-img\" src=\"/static/res/logo/\"/>\n   <img class=\"rich_pages wxw-img\" src=\"/static/res/logo/\"/>\n  </span>\n </section>\n <p style='-webkit-tap-highlight-color: transparent;margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;caret-color: rgba(0, 0, 0, 0);color: rgb(34, 34, 34);font-family: -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);text-align: center;line-height: 1.75em;'>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </p>\n <p style=\"display: none;\">\n  <mp-style-type data-value=\"3\">\n  </mp-style-type>\n </p>\n</div>\n",
  "publish_time": 1750128715,
  "mp_id": "MP_WXS_3975077766",
  "pic_url": "https://mmbiz.qlogo.cn/mmbiz_jpg/lVFg8Ny0F8u9QmZtgeEsojnsIfYq2Pov68ZiczGNHgaaicDNJrUThIna8CgibCr5fpicc6f6hcFdURws7tJIricicjOA/0?wx_fmt=jpeg",
  "mp_name": "Insight数据库"
}